Literature DB >> 10551864

Manipulating the amyloid-beta aggregation pathway with chemical chaperones.

D S Yang1, C M Yip, T H Huang, A Chakrabartty, P E Fraser.   

Abstract

Amyloid-beta (Abeta) assembly into fibrillar structures is a defining characteristic of Alzheimer's disease that is initiated by a conformational transition from random coil to beta-sheet and a nucleation-dependent aggregation process. We have investigated the role of organic osmolytes as chemical chaperones in the amyloid pathway using glycerol to mimic the effects of naturally occurring molecules. Osmolytes such as the naturally occurring trimethylamine N-oxide and glycerol correct folding defects by preferentially hydrating partially denatured proteins and entropically stabilize native conformations and polymeric states. Trimethylamine N-oxide and glycerol were found to rapidly accelerate the Abeta random coil-to-beta-sheet conformational change necessary for fiber formation. This was accompanied by an immediate conversion of amorphous unstructured aggregates into uniform globular and possibly nucleating structures. Osmolyte-facilitated changes in Abeta hydration also affected the final stages of amyloid formation and mediated transition from the protofibrils to mature fibers that are observed in vivo. These findings suggest that hydration forces can be used to control fibril assembly and may have implications for the accumulation of Abeta within intracellular compartments such as the endoplasmic reticulum and in vitro modeling of the amyloid pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551864     DOI: 10.1074/jbc.274.46.32970

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption.

Authors:  C M Yip; J McLaurin
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

2.  Alpha(1)-Antitrypsin Deficiency.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

3.  Concentration effect on the aggregation of a self-assembling oligopeptide.

Authors:  S Y Fung; C Keyes; J Duhamel; P Chen
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

4.  Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils.

Authors:  Jan Bieschke; Martin Herbst; Thomas Wiglenda; Ralf P Friedrich; Annett Boeddrich; Franziska Schiele; Daniela Kleckers; Juan Miguel Lopez del Amo; Björn A Grüning; Qinwen Wang; Michael R Schmidt; Rudi Lurz; Roger Anwyl; Sigrid Schnoegl; Marcus Fändrich; Ronald F Frank; Bernd Reif; Stefan Günther; Dominic M Walsh; Erich E Wanker
Journal:  Nat Chem Biol       Date:  2011-11-20       Impact factor: 15.040

5.  Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant.

Authors:  Zoya Ignatova; Lila M Gierasch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-09       Impact factor: 11.205

6.  Effect of osmotic stress and heat shock in recombinant protein overexpression and crystallization.

Authors:  Natalia Oganesyan; Irina Ankoudinova; Sung-Hou Kim; Rosalind Kim
Journal:  Protein Expr Purif       Date:  2006-10-10       Impact factor: 1.650

7.  Proline to the rescue.

Authors:  Mark T Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

8.  Time-dependent DNA condensation induced by amyloid beta-peptide.

Authors:  Haijia Yu; Jinsong Ren; Xiaogang Qu
Journal:  Biophys J       Date:  2006-10-06       Impact factor: 4.033

Review 9.  The therapeutic potential of chemical chaperones in protein folding diseases.

Authors:  Leonardo Cortez; Valerie Sim
Journal:  Prion       Date:  2014-05-12       Impact factor: 3.931

10.  Effect of nanomolar concentrations of sodium dodecyl sulfate, a catalytic inductor of alpha-helices, on human calcitonin incorporation and channel formation in planar lipid membranes.

Authors:  Silvia Micelli; Daniela Meleleo; Vittorio Picciarelli; Maria G Stoico; Enrico Gallucci
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.